Vergleich

Recombinant Human Matrix Metalloproteinase-9 (MMP-9)

ArtNr 230-30037-10
Hersteller Raybiotech
Menge 10 ug
Quantity options 10 ug 100 ug 250 ug 50 ug
Kategorie
Typ Proteins
Format Lyophilized
Applikationen WB, IP, ELISA, Dot
Specific against Human (Homo sapiens)
Host Human
Konjugat/Tag HIS
Purity >95% - SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Applications
Protein-protein Interaction, Post-translational Modifications, ELISA, EIA, Western Blotting, Dot Blotting, Immunoprecipitation, Protein Array, etc.
Manufacturer - Category
Proteins|Recombinant Proteins|Human Proteins|Enzymes & Inhibitors
Manufacturer - Conjugate / Tag
N-terminal histidine tag
Shipping Temperature
Ambient temperature
Storage Conditions
-20°C
Molecular Weight
Recombinant protein product has a calculated molecular mass of ˆ¼75 kDa. Due to the abundant glycosylation, it migrates as approximately ˆ¼120 kDa protein bands in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. After deglycosylation under native and denature conditions, the protein presented as one reduced ˆ¼75 kDa band. See deglycosylation analysis image below.
Gene Symbols
MMP9
UNSPSC Code
12352202
Formulation
Lyophilized from a 0.2 µm filtered solution in PBS
Expressed Region
Ala20-Asp707
Protein Name & Synonyms
Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, 92 kDa type IV collagenase, Gelatinase B, GELB, Matrix Metallopeptidase 9, CLG4B, Matrix Metallopeptidase 9, Gelatinase B, Macrophage Gelatinase, Type V Collagenase, MandP2.
Format
Lyophilized powder
Purification
His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Concentration
Determined by Pierce BCA protein assay kit (lot specific)
Reconstitution
Briefly spin the vial and bring the contents to the bottom prior to opening. It is recommended to reconstitute at 0.5 - 1 mg/mL with sterile deionized water.
Endotoxin Level
Not determined
Preservative
None
SDS-PAGE Image
Figure 1. Deglycosylation analysis of purified recombinant proteins. The same amount of purified proteins were untreated (Lane 2) or treated with protein deglycosylation enzymes under native (Lane 3) or reducing (Lane 4) conditions. Deglycosylation treatment resulted in a mobility shift of the protein to produce one reduced band at the expected size (ˆ¼75 kDa), thus indicating that the untreated recombinant protein (Lane 2, ˆ¼120 kDa) was glycosylated.Lane 1, protein standard ladder (kDa).Lane 2, untreated protein.Lane 3, treated protein with deglycosylation enzymes under native conditions.Lane 4, treated protein with deglycosylation enzymes under denature conditions.Lane 5, deglycosylation enzymes only without target proteins.
Custom Labeling Request
We can custom label this protein with biotin or fluorescent dyes (choose from violet, blue, green or red). Request now.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen